Pharma Medical News

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Medtronic Demonstrates Positive Results on First Pacemaker Designed for Use with MRI
Medtronic, 05/15/09

New data announced at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, demonstrate that patients implanted with the investigational EnRhythm MRI SureScan pacing system experienced no complications related to the use of magnetic resonance imaging. Sponsored by Medtronic, Inc., the study confirms that the pacing system can help cardiac device patients benefit from the use of MRI, a critical imaging technique commonly used in disease diagnosis. Currently, due to safety considerations, there are no implantable pacemakers or defibrillators approved for use with MRI in the United States. Commercially released in Europe last fall, the EnRhythm MRI SureScan system is the world's first and only pacing system designed and approved for use with MRI.

<< Previous
ImmunoGen, Inc. Announces Trastuzumab-DM1 Presentations at the...

Next >>
Novartis receives approval from FDA to market Prevacid 24HR as...